References
- SubbaraoKKlimovAKatzJCharacterization of an avian influenza A (H5N1) virus isolated from a child with fatal respiratory illnessScience199827953493933969430591
- NicholKLTreanorJJVaccines for seasonal and pandemic influenzaJ Infect Dis2006194Suppl 2S111S11817163383
- PalesePShawMLOrthomyxoviridae: the viruses and their replicationKnipeDMHowleyPMFields VirologyPhiladelphia, PALippincott-Raven Publishers200716471689
- OsterhausAFouchierRRimmelzwaanGTowards universal influenza vaccines?Philos Trans R Soc Lond B Biol Sci201136615792766277321893539
- CoxMMPatriarcaPATreanorJFluBlok, a recombinant hemagglutinin influenza vaccineInfluenza Other Respir Viruses20082621121919453397
- WeiCJXuLKongWPComparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virusJ Virol200882136200620818417563
- CornelissenLAde VriesRPde Boer-LuijtzeEARigterARottierPJde HaanCAA single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1PLoS One201055e1064520498717
- WeldonWCWangBZMartinMPKoutsonanosDGSkountzouICompansRWEnhanced immunogenicity of stabilized trimeric soluble influenza hemagglutininPLoS One201059pii:e12466
- LoeffenWLde VriesRPStockhofeNVaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1) 2009 influenza virusVaccine20112981545155021219983
- de VriesRPSmitCHde BruinEGlycan-dependent immunogenicity of recombinant soluble trimeric hemagglutininJ Virol20128621117351174422915811
- WangCCChenJRTsengYCGlycans on influenza hemagglutinin affect receptor binding and immune responseProc Natl Acad Sci U S A200910643181371814219822741
- PrabakaranMMadhanSPrabhuNQiangJKwangJGastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infectionJ Virol20108473201320920071572
- UleryBDKumarDRamer-TaitAEMetzgerDWWannemuehlerMJNarasimhanBDesign of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseasesPLoS One201163e1764221408610
- KipperMJShenEDetermanASNarasimhanBDesign of an injectable system based on bioerodible polyanhydride microspheres for sustained drug deliveryBiomaterials200223224405441212219831
- HuntimerLWilson WelderJHRossKSingle immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responsesJ Biomed Mater Res B Appl Biomater20131011919823143744
- KipperMJWilsonJHWannemuehlerMJNarasimhanBSingle dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanismJ Biomed Mater Res A200676479881016345084
- HuntimerLMRossKADarlingRJPolyanhydride nanovaccine platform enhances antigen-specific cytotoxic T cell responsesTechnology201422171175
- WoodlandDLHoganRJZhongWCellular immunity and memory to respiratory virus infectionsImmunol Res2001241536711485209
- ThomasPGKeatingRHulse-PostDJDohertyPCCell-mediated protection in influenza infectionEmerg Infect Dis2006121485416494717
- RossKALoydHWuWStructural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticlesJ Biomed Mater Res A2014102114161416824443139
- BuehlerJLagerKVincentAMillerCThackerEJankeBIssues encountered in development of enzyme-linked immunosorbent assay for use in detecting influenza A virus subtype H5N1 exposure in swineJ Vet Diagn Invest201426227728124464555
- WangWXieHYeZVassellRWeissCDCharacterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization asssaysJ Virol Methods2010165230531020153374
- OlsenJCGene transfer vectors derived from equine infectious anemia virusGene Ther1998511148114879930301
- TallmadgeRLBrindlyMASalmansJMealeyRHMauryWCarpenterSDevelopment and characterization of an equine infectious anemia virus Env-pseudotyped reporter virusClin Vaccine Immunol200815713814017978010
- ConixAPoly[1,3-bis(p-carboxyphenoxy)-propane anhydride]Macromol Synth196629598
- TorresMPVogelBMNarasimhanBMallapragadaSKSynthesis and characterization of novel polyanhydrides with tailored erosion mechanismsJ Biomed Mater Res A200676110211016138330
- DetermanASGrahamJRPfeifferKANarasimhanBThe role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheresJ Microencapsul200623883284317390625
- Chavez-SantoscoyAVHuntimerLMRamer-TaitAEWannemuehlerMNarasimhanBHarvesting murine alveolar macrophages and evaluating cellular activation induced by polyanhydride nanoparticlesJ Vis Exp201264e388322710245
- AlsharifiMFuruyaYBowdenTRIntranasal flu vaccine protective against seasonal and H5N1 avian influenza infectionsPLoS One200944e533619401775
- UleryBDPetersenLKPhanseYRational design of pathogen-mimicking amphiphilic materials as nanoadjuvantsSci Rep2011119822355713
- JolliffeeITPrincipal Component AnalysisSecaucus, NJSpringer2002
- KoreniusTLaurikkalaJJuholaMOn principal component analysis, cosine, and Euclidean measures in information retrievalInf Sci20071772248934905
- BroderickSRAouragHRajanKData mining of Ti–Al semi-empirical parameters for developing reduced order modelsPhysica B20114061120552060
- McDonaldRSSambolARHeimbuchBKBrownTLHinrichsSHWanderJDProportional mouse model for aerosol infection by influenzaJ Appl Micro20121134767778
- Centers for Disease Control and Prevention (CDC) [webpage on the Internet]Vaccine effectiveness-how well does the flu vaccine work? Available from: http://www.cdc.gov/flu/about/qa/vaccineeffect.htmAccessed June 12, 2014
- US Food and Drug AdministrationH5N1 influenza virus vaccine, manufactured by Sanofi Pasteur, Inc. questions and answers Available from http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm080753.htmAccessed May 14, 2014
- McElhaneyJEInfluenza vaccine responses in older adultsAgeing Res Rev201110337938821055484
- HaynesLSwainSLWhy aging T cells fail: Implications for vaccinationImmunity200624666366616782020
- SheridanPAPaichHAHandyJObesity is associated with impaired immune response to influenza vaccination in humansInt J Obes (Lond)20123681072107722024641
- McKinstryKKStruttTMSwainSLHallmarks of CD4 T cell immunity against influenzaJ Intern Med2011269550751821362069
- IchinoheTKawaguchiATamuraSIntranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challengeMicrobes Infect20079111333134017890128
- PetersenLKPhaseYRamer-TaitAEWannemuehlerMJNarasimhanBAmphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigenMol Pharm20129487488222380593